General Information of Disease (ID: DISWSHC6)

Disease Name Interstitial lung disease
Synonyms interstitial lung disease; ILD
Disease Class CB40-CB7Z: Respiratory system disease
Definition
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Disease Hierarchy
DIS1LT8E: Lung disease
DISWSHC6: Interstitial lung disease
ICD Code
ICD-11
ICD-11: CB0Z
Expand ICD-11
'CB0Z
Expand ICD-10
'J80-J84; 'J84.1; 'J84.8; 'J84.9
Disease Identifiers
MONDO ID
MONDO_0015925
MESH ID
D017563
UMLS CUI
C5441745
MedGen ID
1788738
HPO ID
HP:0006530
Orphanet ID
182095
SNOMED CT ID
233703007

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
PC-SOD DMUHDX3 Phase 2 NA [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032052)